These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 181911)

  • 21. Effects of interferon on cell and virus growth in transformed human cell lines.
    Fuse TK; Morinaga N
    J Gen Virol; 1976 Oct; 33(1):7-15. PubMed ID: 185329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of interferon actions using partially resistant cell variants.
    Sen G; Belkowski L; Kusari J
    Prog Clin Biol Res; 1985; 202():175-82. PubMed ID: 2421300
    [No Abstract]   [Full Text] [Related]  

  • 23. Action of interferon in enucleated cells.
    Young CS; Pringle CR; Follett EA
    J Virol; 1975 Feb; 15(2):428-9. PubMed ID: 163365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evidences that priming is a non-antiviral function of interferon.
    Rosztóczy I
    Acta Microbiol Acad Sci Hung; 1974; 21(3-4):305-9. PubMed ID: 4372864
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanisms of interferon induced transfer of viral resistance between animal cells.
    Blalock JE; Baron S
    J Gen Virol; 1979 Feb; 42(2):363-72. PubMed ID: 217961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lectin and cholera toxin binding to guinea pig tumor (104C1) cell surfaces before and after glycosphingolipid incorporation.
    Basu M; Basu S; Shanabruch WG; Moskal JR; Evans CH
    Biochem Biophys Res Commun; 1976 Jul; 71(1):385-92. PubMed ID: 822849
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiviral activity of interferons.
    Friedman RM
    Bacteriol Rev; 1977 Sep; 41(3):543-67. PubMed ID: 199154
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of interferon in replication of virulent and attenuated strains of measles virus.
    Mirchamsy H; Rapp F
    J Gen Virol; 1969 Jun; 4(4):513-22. PubMed ID: 4308487
    [No Abstract]   [Full Text] [Related]  

  • 29. Bovine type II interferon: activity in heterologous cells.
    Babiuk LA; Rouse BT
    Intervirology; 1977; 8(4):250-6. PubMed ID: 194868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selectivity of interferon action: hormonal induction of tyrosine aminotransferase in rat hepatoma cells is much less sensitive to interferon than the replication of vesicular stomatitis virus or reovirus.
    Vassef A; Spencer C; Gelehrter TD; Lengyel P
    Biochim Biophys Acta; 1974 Jun; 353(1):115-20. PubMed ID: 4152137
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
    Maheshwari RK; Jay FT; Friedman RM
    Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell killing by viruses. III. The interferon system and inhibition of cell killing by vesicular stomatitis virus.
    Marcus PI; Sekellick MJ
    Virology; 1976 Feb; 69(2):378-93. PubMed ID: 176779
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid increase in guanosine 3',5'-cyclic-monophosphate interferon treated mouse leukemia L1210 cells: relationship to the development of the antiviral state and inhibition of cell multiplication.
    Tovey MG; Rochette-Egly C
    Virology; 1981 Dec; 115(2):272-81. PubMed ID: 6171931
    [No Abstract]   [Full Text] [Related]  

  • 35. [Potentiation of antiviral action of interferon by actinomycin D].
    Fournier F; Chany C; Rousset S
    C R Acad Hebd Seances Acad Sci D; 1970 Aug; 271(5):549-51. PubMed ID: 4318863
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
    Allen PT; Schellekens H; Van Griensven LJ; Billiau A
    J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of interferon treatment on vesicular stomatitis virus (VSV): release of unusual particles with low infectivity.
    Maheshwari RK; Friedman RM
    Virology; 1980 Mar; 101(2):399-407. PubMed ID: 6244697
    [No Abstract]   [Full Text] [Related]  

  • 38. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors.
    Thacore HR; Youngner JS
    Virology; 1973 Dec; 56(2):512-22. PubMed ID: 4357054
    [No Abstract]   [Full Text] [Related]  

  • 39. Specific high-affinity binding of 125I-labeled mouse interferon to interfevon resistant embryonal carcinoma cells in vitro.
    Aguet M; Gresser I; Hovanessian AG; Bandu MT; Blanchard B; Blangy D
    Virology; 1981 Oct; 114(2):585-8. PubMed ID: 6170161
    [No Abstract]   [Full Text] [Related]  

  • 40. Rescue of vesicular stomatitis virus from homologous and heterologous interferon-induced resistance in human cell cultures by poxviruses.
    Thacore HR
    Infect Immun; 1976 Jul; 14(1):311-4. PubMed ID: 181327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.